Loading Events

Palatin Virtual KOL Event – Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance

DATE: May 8, 2024
TIME: 10:00 AM EDT

About The Event

Join Palatin Technologies for a virtual KOL event featuring Jesse Richards, DO (Oklahoma State University College of Osteopathic Medicine), who will discuss the current treatment landscape for obesity, the need for new treatments with alternative mechanisms of action and how combining a melanocortin agonist with incretins can optimize treatment.

The event will focus on the Company’s metabolic program evaluating novel selective melanocortin-4 receptor (MCR4) agonists as a treatment for obesity in combination with a GLP-1 agonist. Palatin’s Phase 2 clinical study is targeted to start mid-calendar year 2024, with topline data readout expected by end of calendar year 2024.

A live question and answer session will follow the formal presentation.